CureMetrix Company
CureMetrix is committed to advancing AI-based technology that improves breast cancer and heart disease detection across the globe.
Funding Status:
Early Stage Venture
Industry:
Med Tech
Estimated Revenue:
$1M to $10M
Technology:
['BioTech & HealthTech']
Headquarters:
San Diego, California, United States
Last Funding Date:
2017-01-01
Last Funding Type:
Series A
Employee Number:
11-50
Investors Number:
2
Founded Date:
2014